Search
for
Sort by
Research 931–960 of 1000+
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Dermatologic therapy: December 1987 to December 1988
- Dermatologic therapy: December 1986 to December 1987
- Dermatologic therapy: December 1984 through December 1985
- Dermatologic Changes Associated With Interleukin 2 Administration
- Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Dermatologic manifestations of endocrine disorders
- Periorbital Rejuvenation: A Review of Dermatologic Treatments
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Dermatologic Features of Classic Movie Villains
- Dermatologic care of the transgender patient
- Update on the dermatologic use of systemic glucocorticosteroids
- Top applications of dermatologic ultrasonography that can modify management
- Dermatologic research techniques
- Dermatologic Side Effects of Psychotropic Medications
- DERMATOLOGIC INVESTIGATION OF ALOPECIA IN RHESUS MACAQUES (MACACA MULATTA)
- Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- The Physician's Guide to Platelet-Rich Plasma in Dermatologic Surgery Part II: Clinical Evidence
- Dermatologic manifestations in patients of renal disease on hemodialysis
- Wigs and hairpieces: Evaluating dermatologic issues
- Dermatologic Conditions in Transgender Populations
- Dermatologic Problems of Older Women
- The Physician's Guide to Platelet-Rich Plasma in Dermatologic Surgery Part I: Definitions, Mechanisms of Action, and Technical Specifications
- DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management